Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Adapazarı
Clinical trial register · Turkey

Clinical Trials in Adapazarı, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca17 Eli Lilly and Company3 Merck Sharp & Dohme LLC2 AbbVie2 Sakarya University2
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Adapazarı

40 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Not yet open
Rotational Atherectomy and Drug-Coated Balloon Angioplasty With Embolic Protection for Superficial Femoral Artery Occlusions
NCT07803718Peripheral Artery Disease, Atherectomy in Diseased Lower Extremity Arteries
Sakarya University
Not applicable
60
Adapazarı
2026-09-01
Recruiting
AstraZeneca
Phase 3
2,800
Adapazarı, Ankara, Antalya, Dinar, İzmit, Kahramanmaraş, Kayseri, Kazımkarabekir
2026-09-01
Active, closed
Using Wet Towel During Labor
NCT07808840Labor Pain, Comfort, Labor Anxiety
Sakarya University
Not applicable
60
Adapazarı
2026-08-25
Recruiting
Cervical Epidural Block in Chronic Neck Pain
NCT07787741Chronic Neck Pain, Cervical Radiculopathy
Alİ Eman, MD
Not applicable
60
Adapazarı
2026-07-01
Recruiting
AstraZeneca
Phase 3
4,500
Adana, Adapazarı, Ankara, Antalya, Istanbul
2026-06-29
Recruiting
AstraZeneca
Phase 3
420
Adapazarı, Antalya, Istanbul, Kocaeli, Mezitli
2026-05-05
Recruiting
ALİEMAN
Not applicable
60
Adapazarı
2026-03-10
Recruiting
AstraZeneca
Phase 2
124
Adapazarı, Ankara, Kahramanmaraş, Kocaeli
2026-02-10
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Adana, Adapazarı, Ankara, Antalya, Diyarbakır, Edirne, Gaziantep, Istanbul
2025-12-12
Recruiting
AbbVie
Phase 2/3
490
Adapazarı, Adana, Ankara, Istanbul, Konya, Samsun
2025-12-10
Active, closed
AstraZeneca
Phase 2
222
Adana, Adapazarı, Kahramanmaraş, Kayseri, Kocaeli
2025-12-05
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Adana, Ankara, Çankaya, Fatih, Kadıköy, Adapazarı, Istanbul
2025-11-30
Recruiting
Kedrion S.p.A.
Phase 3
40
Ankara, Yenimahalle, Edirne, Izmir, Mersin, Adapazarı
2025-08-13
Recruiting
AstraZeneca
Phase 2
100
Adapazarı, Erzurum, Fatih-Istanbul, Istanbul
2025-07-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Adapazarı, Adana, Ankara, Istanbul, Konya
2025-05-13
Recruiting
Eli Lilly and Company
Phase 3
700
Adana, Adapazarı, Ankara, Antalya, Edirne, Gaziantep, Istanbul, Izmir
2025-03-27
Recruiting
AbbVie
Phase 1/2
252
Ankara, Adapazarı, Adana, Denizli, Istanbul, Konya, Samsun
2025-03-06
Recruiting
AstraZeneca
Phase 3
5,000
Adana, Adapazarı, Altındağ, Ankara, Antalya, Haliliye, Kahramanmaraş, Kayseri
2025-03-03
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Adapazarı, Ankara, Antalya, Istanbul, Izmir, İzmit, Mersin, Samsun
2025-01-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Sıhhiye, Adapazarı, Tekirdağ, Adana, Ankara, Istanbul, Kayseri, Trabzon
2024-10-21
Active, closed
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
NCT06449222Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers
DrugsEribulin·Pumitamig·Gemcitabine·Paclitaxel
BioNTech SE
Phase 2
83
Adana, Adapazarı, Ankara, Istanbul
2024-08-26
Recruiting
AstraZeneca
Phase 3
788
Adapazarı, Altındağ-Ankara, Ankara, Çankaya, Istanbul, Kayseri
2024-08-01
Recruiting
AstraZeneca
Phase 3
582
Adapazarı, Ankara, Goztepe Istanbul, Izmir, Küçükçekmece, Seyhan
2024-04-29
Recruiting
AstraZeneca
Phase 3
675
Adapazarı, Ankara, Antalya, Diyarbakır, Istanbul
2024-04-11
Active, closed
AstraZeneca
Phase 3
2,554
Adana, Adapazarı, Afyonkarahisar, Ankara, Antalya, Bursa, Istanbul, Kahramanmaraş
2024-03-29
Recruiting
GlaxoSmithKline
Phase 3
864
Adapazarı, Ankara, Antalya, Istanbul
2024-03-21
Active, closed
Samsung Bioepis Co., Ltd.
Phase 3
555
Adapazarı, Ankara, Bağcılar, Balgat, Çubuk, Istanbul, İzmit, Kavaklıdere
2024-03-12
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Adapazarı, Ankara, Battalgazi, Çankaya, Istanbul, Kepez, Mezitli, Ortahisar
2024-02-05
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Adapazarı, Ankara, Bakirkoy / Istanbul, Izmir, Kadiköy, Mersin, Samsun, Sihhiye/Ankara
2023-12-11
Active, closed
AstraZeneca
Phase 3
1,902
Adapazarı, Ankara, Istanbul, Kayseri, Samsun
2023-11-14
Active, closed
AstraZeneca
Phase 3
1,835
Adapazarı, Ankara, Bursa, Dinar, Kahramanmaraş, Kayseri, Kocaeli
2023-11-07
Recruiting
Hoffmann-La Roche
Phase 3
230
Adapazarı, Ankara, Bakirkoy / Istanbul, Diyarbakır, Istanbul, Izmir, Seyhan, Sihhiye/Ankara
2023-09-08
Active, closed
Eli Lilly and Company
Phase 3
8,000
Adana, Adapazarı, Altindağ, Ankara, Antalya, Bursa, Diyarbakır, Edirne
2022-10-04
Active, closed
AstraZeneca
Phase 3
791
Adapazarı, Ankara, Antalya, Çankaya, Edirne, Istanbul, Izmir, Konya
2022-02-18
Active, closed
AstraZeneca
Phase 3
363
Adapazarı, Ankara, Istanbul, Izmir, Kahramanmaraş, Kayseri, Kocaeli
2022-02-15
Active, closed
argenx
Phase 3
173
Adapazarı, Ankara, Izmir, Kocaeli, Mersin, Tekirdağ, Trabzon
2021-11-17
Active, closed
Geron Corporation
Phase 3
327
Ankara, Istanbul, Izmir, Mersin, Adapazarı
2021-04-12
Active, closed
Tesaro, Inc.
Phase 3
785
Adapazarı, Ankara, Istanbul
2019-07-18
Active, closed
AstraZeneca
Phase 3
1,246
Adana, Adapazarı, Ankara, Edirne, Istanbul, Izmir
2018-09-27
Active, closed
AstraZeneca
Phase 3
216
Adana, Adapazarı, Ankara, Istanbul, Izmir
2018-07-19
Rows per page Showing 1–40 of 40
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/adapazar

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 40 of those studies with a site in Adapazarı.

How many clinical trials are recruiting in Adapazarı?

23 of the 40 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Adapazarı), 40 studies
PhaseStudiesRecruitingShare
Phase 3291672.5%
Phase 25312.5%
Not applicable4210%
Phase 1/2112.5%
Phase 2/3112.5%

Most active sponsors

Lead sponsors with the most studies (Adapazarı)
Lead sponsorStudiesRecruiting
AstraZeneca179
Eli Lilly and Company32
AbbVie22
Hoffmann-La Roche21
Merck Sharp & Dohme LLC22
Sakarya University20
Alİ Eman, MD11
ALİEMAN11
argenx10
Ascentage Pharma Group Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.